Share Price | Vaxxinity, Inc. Stock Analysis & Recommendation

Q: What does Vaxxinity, Inc. do?

Overview: Vaxxinity, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.Financial Snapshot: Net Profit: -11 Million (Quarterly Results - Dec 2023) Market Cap: USD 0.01 Million (Micro Cap)Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -1.14 Return on Equity: -424.60% Price to Book: 0.00Contact Details: Details: No Company Details Available Registrar Address: Not available.

Q: Is Vaxxinity, Inc. technically bullish or bearish?

As of 29 August 2025, the technical trend for Vaxxinity, Inc. has changed from mildly bearish to mildly bullish. The weekly MACD indicates a mildly bullish stance, supported by a mildly bullish daily moving average. However, the KST shows a bullish weekly signal but a bearish monthly signal, and Bollinger Bands are mildly bearish on the weekly timeframe. The stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -98.0% versus the S&P 500's 12.22%. Overall, the current technical stance is mildly bullish, but the strength is tempered by mixed signals from other indicators.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

100

Shareholding (Dec 2023)

FII

0.42%

Held by 11 FIIs

DII

93.71%

Held by 6 DIIs

Promoter

1.20%

How big is Vaxxinity, Inc.?

22-Jun-2025

As of Jun 18, Vaxxinity, Inc. has a market capitalization of 0.01 million, with net sales of 0.00 million and a net profit of -56.93 million over the latest four quarters. As of Dec 23, the company reports shareholder's funds of 13.41 million and total assets of 44.35 million.

View full answer

What does Vaxxinity, Inc. do?

22-Jun-2025

Vaxxinity, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $11 million and a market cap of $0.01 million. Key metrics indicate it is not profitable, with a negative return on equity and no dividend yield.

View full answer

Is Vaxxinity, Inc. technically bullish or bearish?

20-Sep-2025

As of August 29, 2025, Vaxxinity, Inc. shows a mildly bullish trend, supported by a bullish MACD and daily moving average, despite mixed signals from the KST and Bollinger Bands, and a significant year-to-date underperformance of -98.0% compared to the S&P 500's 12.22%.

View full answer

Compare Vaxxinity, Inc. with Similar Stocks

Black Diamond Therapeutics, Inc.Mersana Therapeutics, Inc.InflaRx NV

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 0 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.14

Return on Equity

-424.60%

Price to Book

0.00

Revenue and Profits:

Net Sales:

(Quarterly Results - Dec 2023)

Net Profit:

-11 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

9900.0%

6 Months

9900.0%

1 Year

4900.0%

2 Years

-98.55%

3 Years

-99.75%

4 Years

-99.84%

5 Years

0.0%

Vaxxinity, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-100.00%

EBIT Growth (5y)

-334.77%

EBIT to Interest (avg)

-49.14

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.14

Sales to Capital Employed (avg)

0.00

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

14.05%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.10

EV to EBIT

0.24

EV to EBITDA

0.25

EV to Capital Employed

7.24

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

3033.28%

ROE (Latest)

-424.60%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bullish

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2023

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 13 Schemes (4.66%)

Foreign Institutions

Held by 11 Foreign Institutions (0.42%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'23 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2023 is 0.00% vs 0.00% in Sep 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2023 is 12.98% vs 6.43% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.20",
          "val2": "-12.80",
          "chgp": "12.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.40",
          "val2": "-13.10",
          "chgp": "12.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 0.00% vs -100.00% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 24.34% vs 45.19% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-56.10",
          "val2": "-74.30",
          "chgp": "24.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.50",
          "chgp": "40.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-56.90",
          "val2": "-75.20",
          "chgp": "24.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'23 - QoQ

Dec'23

Sep'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-11.20

-12.80

12.50%

Interest

0.20

Exceptional Items

0.00

Consolidate Net Profit

-11.40

-13.10

12.98%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2023 is 0.00% vs 0.00% in Sep 2023

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2023 is 12.98% vs 6.43% in Sep 2023

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-56.10

-74.30

24.50%

Interest

0.70

0.50

40.00%

Exceptional Items

0.00

Consolidate Net Profit

-56.90

-75.20

24.34%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is 0.00% vs -100.00% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 24.34% vs 45.19% in Dec 2022

All Annual Results

Company CV

About Vaxxinity, Inc.

Vaxxinity, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Vaxxinity, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Vaxxinity, Inc.?

Watch in Real-Time

What does Vaxxinity, Inc. do?

Is Vaxxinity, Inc. technically bullish or bearish?

Compare Vaxxinity, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Dec 2023

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Dec'23 - QoQ

Annual Results Snapshot (Consolidated) - Dec'23

About Vaxxinity, Inc.

Company Coordinates